"Novartis signs agreement to acquire Anthos for $925m upfront" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been ...

Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the activated form ...

Novartis: 1996 – 2013 Dr Daniel Vasella was the first CEO of the newly merged company. Vasella was hired by Sandoz back in 1988 and remained there until 1992 when he was promoted to CEO of its ...

In November, Isis Pharmaceuticals (Carlsbad, CA) announced the departure of its longstanding partner, Novartis Pharmaceuticals (Basel, Switzerland), leaving the small biotech company to underwrite ...

Basel, January 13, 2025 - Novartis is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the validity of the Entresto ...

Chairman and former Chief Executive Officer (CEO), Novartis, Basel, Switzerland. Daniel Vasella, M.D., was appointed Chairman of Novartis in April 1999, having served as CEO and executive member ...